Suppr超能文献

微创外科与开腹手术治疗上皮性卵巢癌的疗效和安全性:系统评价和荟萃分析。

Efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer: A systematic review and meta-analysis.

机构信息

Department of Obstetrics and Gynecology, Nagoya University, Aichi, Japan.

Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan.

出版信息

Gynecol Oncol. 2024 Nov;190:42-52. doi: 10.1016/j.ygyno.2024.08.011. Epub 2024 Aug 16.

Abstract

OBJECTIVE

To examine the efficacy and safety of minimally invasive surgery (MIS) and conventional abdominal surgery for epithelial ovarian cancer (EOC), stratified by treatment type.

METHODS

A systematic review and meta-analysis were conducted by an Expert Panel of the Japan Society of Gynecologic Oncology Ovarian Cancer Committee. Several academic databases, including PubMed/MEDLINE, Cochrane Database, and Ichushi were searched by the Japan Medical Library Association on November 11, 2023, using the keywords "epithelial ovarian cancer", "minimally invasive surgery", "laparoscopic", and "robot-assisted". Articles describing MIS treatment for EOC compared with conventional abdominal surgery were independently assessed by two authors. The primary outcomes were survival and perioperative adverse events.

RESULTS

After screening 1114 studies, 35 articles were identified, including primary staging surgery (PSS) for early-stage EOC EOC (n = 20) and neoadjuvant chemotherapy following interval debulking surgery (NACT-IDS; n = 10) and upfront primary debulking surgery (PDS; n = 5) for advanced-stage EOC. These studies included 29,888 patients (7661 undergoing MIS and 22,227 undergoing abdominal surgery). Patients receiving MIS and abdominal surgery had similar overall survival (PSS: odds ratio [OR] 1.02, 95% confidence interval [CI] 0.75-1.37; NACT-IDS: OR 0.93, 95%CI 0.25-3.44 and PDS: OR 0.66, 95%CI 0.36-1.22, all P > 0.05). MIS showed perioperative complication rates comparable to those of abdominal surgery (intraoperative and postoperative, all treatment types P ≥ 0.05). However, the rate of lymph node dissection in early-stage EOC (PSS: OR 0.49, 95%CI0.26-0.91) and multivisceral resections in advanced-stage EOC (NACT-IDS: OR 0.27 95%CI 0.16-0.44 and PDS: OR 0.27, 95%CI 0.16-0.44) was lower in MIS than in abdominal surgery (all P < 0.05).

CONCLUSION

MIS did not negatively impact the survival and perioperative complications of patients with EOC compared to abdominal surgery. While MIS is a viable option, varied case selection and surgical procedures suggest potential bias, requiring further validation studies.

摘要

目的

按治疗类型分层,研究上皮性卵巢癌(EOC)微创外科(MIS)与传统开腹手术的疗效和安全性。

方法

由日本妇科肿瘤学会卵巢癌委员会专家小组进行系统评价和荟萃分析。日本医学图书馆协会于 2023 年 11 月 11 日使用“上皮性卵巢癌”、“微创外科”、“腹腔镜”和“机器人辅助”等关键词,在几个学术数据库(包括 PubMed/MEDLINE、Cochrane 数据库和 Ichushi)中进行了检索。由两位作者独立评估描述 MIS 治疗 EOC 与传统开腹手术比较的文章。主要结局是生存和围手术期不良事件。

结果

筛选 1114 篇研究后,共确定了 35 篇文章,包括早期 EOC 的初次分期手术(PSS)(n=20)和新辅助化疗后间隔减瘤手术(NACT-IDS;n=10)以及晚期 EOC 的直接初始减瘤手术(PDS;n=5)。这些研究共纳入 29888 例患者(7661 例接受 MIS 治疗,22227 例接受开腹手术)。接受 MIS 和开腹手术的患者总生存率相似(PSS:比值比 [OR] 1.02,95%置信区间 [CI] 0.75-1.37;NACT-IDS:OR 0.93,95%CI 0.25-3.44 和 PDS:OR 0.66,95%CI 0.36-1.22,均 P>0.05)。MIS 的围手术期并发症发生率与开腹手术相当(术中及术后,所有治疗类型 P≥0.05)。然而,早期 EOC 的淋巴结清扫率(PSS:OR 0.49,95%CI0.26-0.91)和晚期 EOC 的多脏器切除术率(NACT-IDS:OR 0.27,95%CI 0.16-0.44 和 PDS:OR 0.27,95%CI 0.16-0.44)在 MIS 中低于开腹手术(均 P<0.05)。

结论

与开腹手术相比,MIS 并未对 EOC 患者的生存和围手术期并发症产生负面影响。虽然 MIS 是一种可行的选择,但不同的病例选择和手术方式表明存在潜在的偏倚,需要进一步的验证研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验